Clinical Trial Update: Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant [Phase 2, Phase 3]

View source ↗

Summary

Announcement of a Phase 2/Phase 3 clinical trial to evaluate the safety and efficacy of a second-generation travoprost intracameral implant for glaucoma, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Travoprost Intracameral Implant (Second Generation) (travoprost)

Snippet

Sponsor: Glaukos Corporation | Conditions: Glaucoma | Phase 2, Phase 3 | Status: RECRUITING